Nicotine addiction treatment segment by type is estimated to lead the market growth during the forecast period
According to a new market research study of “North America Addictions Therapeutics Market Forecast to 2027 - COVID-19 Impact and Analysis by Treatment Type, Drug Type,Treatment Centre, and Distribution Channel,” The North America Addictions Therapeutics market is expected to reach US$ 6,102.31 million by 2027 from US$ 3,715.23 million in 2019. The market is estimated to grow with a CAGR of 6.5% from 2020 to 2027. The report highlights trends prevailing in the North America Addictions Therapeutics market and the factors driving market along with those that act as hindrances.
Based on treatment type, the North America addictions therapeutics market is segmented into nicotine addiction treatment, alcohol addiction treatment, opioid addiction treatment, and other substance addiction treatment. Drug addiction, also referred to as substance disorder, is a type of disease that hampers an individual’s brain, behavior, and metabolic processes leading to an inability to control. Non-medical use and abuse of prescription drugs are becoming severe issues worldwide. Addiction to abusive substances is responsible for the death of millions of people across the world. According to the National Institute on Drug Abuse (NIDA) estimates, ~21 million people across the world had at least one addiction in 2019, out of which only 10% received treatment for the same. The Addiction Center reports state that the number of people undertaking treatments for addictions has increased in recent years. Thus, the rising awareness among people about drug addiction treatment is likely to support the growth of the North America addiction therapeutics market in the coming years. Similarly, awareness campaigns and government efforts to counteract drug abuse and promote medication for all sorts of addiction treatments would fuel the market growth during the forecast period.
The growth of the market is attributed to rising approval of new drugs and launch of digital therapeutics to treat addiction, conduction of various awareness campaigns and government efforts to counteract drug abuse and promote medication. However, high costs associated with drug development is hindering the growth of the addiction therapeutics market.
Indivior PLC, Pfizer Inc.and GlaxoSmithKline plc are among the leading companies operating in the North America addictions therapeutics market.
The report segments in North America Addictions Therapeutics market as follows:
By Treatment Type
By Drug Type
By Treatment Center
By Distribution Channel
By Country
Reasons to Buy
According to a new market research study of “North America Addictions Therapeutics Market Forecast to 2027 - COVID-19 Impact and Analysis by Treatment Type, Drug Type,Treatment Centre, and Distribution Channel,” The North America Addictions Therapeutics market is expected to reach US$ 6,102.31 million by 2027 from US$ 3,715.23 million in 2019. The market is estimated to grow with a CAGR of 6.5% from 2020 to 2027. The report highlights trends prevailing in the North America Addictions Therapeutics market and the factors driving market along with those that act as hindrances.
Based on treatment type, the North America addictions therapeutics market is segmented into nicotine addiction treatment, alcohol addiction treatment, opioid addiction treatment, and other substance addiction treatment. Drug addiction, also referred to as substance disorder, is a type of disease that hampers an individual’s brain, behavior, and metabolic processes leading to an inability to control. Non-medical use and abuse of prescription drugs are becoming severe issues worldwide. Addiction to abusive substances is responsible for the death of millions of people across the world. According to the National Institute on Drug Abuse (NIDA) estimates, ~21 million people across the world had at least one addiction in 2019, out of which only 10% received treatment for the same. The Addiction Center reports state that the number of people undertaking treatments for addictions has increased in recent years. Thus, the rising awareness among people about drug addiction treatment is likely to support the growth of the North America addiction therapeutics market in the coming years. Similarly, awareness campaigns and government efforts to counteract drug abuse and promote medication for all sorts of addiction treatments would fuel the market growth during the forecast period.
The growth of the market is attributed to rising approval of new drugs and launch of digital therapeutics to treat addiction, conduction of various awareness campaigns and government efforts to counteract drug abuse and promote medication. However, high costs associated with drug development is hindering the growth of the addiction therapeutics market.
Indivior PLC, Pfizer Inc.and GlaxoSmithKline plc are among the leading companies operating in the North America addictions therapeutics market.
The report segments in North America Addictions Therapeutics market as follows:
By Treatment Type
- Opioid Addiction Treatment
- Alcohol Addiction Treatment
- Nicotine Addiction Treatment
- Other Substance Addiction Treatment
By Drug Type
- Buprenorphine
- Naltrexone
- Bupropion
- Disulfiram
- Nicotine Replacement Products
- Varenicline
- Others
By Treatment Center
- Inpatient Treatment Center
- Residential Treatment Center
- Outpatient Treatment Center
By Distribution Channel
- Hospital Pharmacies
- Medical stores
- Others
By Country
- United States
- Canada
- Mexico
Reasons to Buy
- Determine prospective investment areas based on a detailed trend analysis of the North America addictions therapeutics market over the next years.
- Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
- Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
- Identify the major channels driving the North America addictions therapeutics market, providing a clear picture of future opportunities that will help analyze, resulting in revenue expansion.
- Channelize resources by focusing on the ongoing programs undertaken by the different countries within the North America addictions therapeutics market.
Table of Contents
1. Introduction
3. Research Methodology
4. Addiction Therapeutics Market - Market Landscape
5. Addiction Therapeutics Market - Key Market Dynamics
6. Addiction Therapeutics Market - North America Analysis
7. Addictions Therapeutics Market- Treatment Type
8. Addictions Therapeutics Market- Drug Type
9. Addictions Therapeutics Market- Treatment Center
10. Addictions Therapeutics Market- Distribution Channel
11. Addiction Therapeutics Market Analysis and Forecasts To 2027 - North America Analysis
12. Impact of COVID-19 Pandemic on North America Addiction Therapeutics Market
14. Company Profiles
15. Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Indivior PLC
- Pfizer Inc
- GlaxoSmithKline plc
- Bausch Health Companies Inc
- Cipla Inc.
- Orexo AB
- Purdue Pharma L.P
- Alvogen
- Camurus AB
- Hikma Pharmaceuticals PLC
